Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Despite these limitations, interest in the compound has continued to grow, with some healthcare providers and wellness clinics offering it through compounding pharmacies under specific circumstances
It can be perceived as withholding a medically necessary treatment, not just a preference
10.1056/NEJMoa1901118 48
To summarize, on one hand the modest upwards trajectory of the obese and diabetic population provides a fertile ground for Pharma companies to sell more for the years to come, however, downside risks remain, including: pricing, compounders and overall competition, which will make it hard for companies like Novo and Lilly to maintain their growth
Davini P, Bigalli A, Lamanna F, Boem A
US$ 23.54
US$ 24.87
US$ 25.42
US$ 24.82
US$ 25.71
US$ 23.66
US$ 19.99
US$ 22.27
US$ 22.96
US$ 26.37
